The World Federation of Socleties of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania

References

• Akiskal H. Dysthymia and cyclothymia in psychiatric practice a century after Kraepelin. J Affect Disord 2001; 62: 31
   Google Scholar
• Altshuler L L, Post R M, Leverich G S, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995; 152: 1130–1138
   PubMed Web of Science ®Google Scholar
• Amann B, Schlösser S, Sterr A, Hummel B, Schäfer M, Padovan C S, Grunze H. Anticonvulsants in the treatment of aggression in the demented elderly. Psychiatric Networks 2000; 3: 87–95
   Google Scholar
• Antonacci D J, Swartz C M. Clozapine treatment of euphoric mania. Ann Clin Psychiatry 1995; 7: 203–206
   PubMedGoogle Scholar
• Arnold L M, McElroy S L, Keck P E. The role of gender in mixed mania. Compr Psychiatry 2000; 41: 83–87
   PubMed Web of Science ®Google Scholar
• Bauer M S, Whybrow P C. Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levo-thyroxine: a preliminary study. Arch Gen Psychiatry. Treatment of refractory rapid cycling with high-dose levo-thyroxine: a preliminary study. Arch Gen Psychiatry 1990; 47: 435–440
   PubMed Web of Science ®Google Scholar
• Bauer M S, Whybrow P C, Winokur A. Rapid cycling bipolar affective disorder. I. Association with grade I hypothyroidism. Arch Gen Psychiatry 1990; 47: 427–432
   PubMed Web of Science ®Google Scholar
• Bauer M, Whybrow P C, Angst J, Versiani M, Möller H-J. WFSBP Task Force on Treatment Guidelines for Unipolar Depressive Disorders (2002) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive disorder,Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatry, 3: 5–43
   PubMedGoogle Scholar
• Benabarre A, Vieta E, Colom F, Martinez A, Reinares M, Corbella B. Treatment of mixed mania with risperidone and mood stabilizers. Can J Psychiatry 2001; 46: 866–867
   PubMed Web of Science ®Google Scholar
• Berk M, Ichim L, Brook S. Olanzapine compared to lithium in mania: A double-blind randomized controlled trial. Int Clin Psychopharmacol 1999; 14: 339–343
   PubMed Web of Science ®Google Scholar
• Black D W, Winokur G, Nasrallah A. Treatment of mania: a naturalistic study of electroconvulsive therapy versus lithium in 438 patients. J Clin Psychiatry 1987; 48: 132–139
   PubMed Web of Science ®Google Scholar
• Bowden C L. Key treatment studies of lithium in manic-depressive illness: efficacy and side effects. J Clin Psychiatry 1998; 59(Suppl 6)13–19
   PubMedGoogle Scholar
• Bowden C L, Brugger A M, Swann A C, Calabrese J R, Janicak P G, Petty F, Dilsaver S C, Davis J M, Rush A J, Small J G, Garza-Trevino E S, Risch S C, Goodnick P J, Morris D D. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 1994; 271: 918–924
   PubMed Web of Science ®Google Scholar
• Calabrese J R, Woyshville M J. A medication algorithm for treatment of bipolar rapid cycling?. J Clin Psychiatry 1995; 56(Suppl 3)11–18
   PubMedGoogle Scholar
• Calabrese J R, Meltzer H Y, Markovitz P J. Clozapine prophylaxis in rapid cycling bipolar disorder. J Clin Psychopharmacol 1991; 11: 396–397
   PubMed Web of Science ®Google Scholar
• Calabrese J R, Woyshville M J, Kimmel S E, Rapport D J. Predictors of valproate response in bipolar rapid cycling. J Clin Psychiatry 1993; 13: 280–283
   Google Scholar
• Calabrese J R, Kimmel S E, Woyshville M J, Rapport D J, Faust C J, Thompson P A, Meltzer H Y. Clozapine for treatment-refractory mania. Am J Psychiatry 1996; 153: 759–764
   PubMed Web of Science ®Google Scholar
• Calabrese J R, Suppes T, Bowden C L, Sachs G S, Swann A, McElroy S L, Kusamakar V, Ascher J A, Earl N L, Greene P L, Monaghan E T. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid cycling bipolar disorder. J Clin Psychiat 2000; 61: 841–850
   PubMed Web of Science ®Google Scholar
• Cassidy F, Murry E, Forest K, Carroll B J. Signs and symptoms of mania in pure and mixed episodes. J Affect Disord 1998; 50: 187–201
   PubMed Web of Science ®Google Scholar
• Cassidy F, Pieper C F, Carroll B J. Subtypes of mania determined by grade of membership analysis. Neuropsycho-pharmacology 2001; 25: 373–383
   PubMedGoogle Scholar
• Chang K D, Ketter T A. Mood stabilizer augmentation with olanzapine in acutely manic children. J Child Adolesc Psycho-pharmacol 2000; 10: 45–49
   PubMed Web of Science ®Google Scholar
• Cohen L S, Friedman J M, Jefferson J W, Johnson E M, Weiner M L. A reevaluation of risk of in utero exposure to lithium. JAMA 1994; 271: 146–150
   PubMed Web of Science ®Google Scholar
• Deltito J A. The effect of valproate on bipolar spectrum temperamental disorders. J Clin Psychiatry 1993; 54: 300–304
   PubMedGoogle Scholar
• Dilsaver S C, Chen Y R, Shoaib A M, Swann A C. Phenomenology of mania: evidence for distinct depressed, dysphoric, and euphoric presentations. Am J Psychiatry 1999; 156: 426–430
   PubMed Web of Science ®Google Scholar
• Dose M, Emrich H E. Acute mania: Practical therapeutic guidelines. CNS Drugs 1995; 3: 427–435
   Google Scholar
• Dubovsky S L, Buzan R D. Novel alternatives and supplements to lithium and anticonvulsants for bipolar affective disorder. J Clin Psychiatry 1997; 58: 224–242
   PubMedGoogle Scholar
• Emilien G, Maloteaux J M, Seghers A, Charles G. Lithium compared to valproic acid and carbamazepine in the treatment of mania: a statistical meta-analysis. Eur Neuropsychopharmacol 1996; 6: 245–252
   PubMed Web of Science ®Google Scholar
• Emrich H M, von Zerssen D, Kissling W, Möller H-J, Windorfer A. Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders. Arch Psychiatr Nervenkr 1980; 229: 1–16
   PubMedGoogle Scholar
• Freeman T W, Clothier J L, Pazzaglia P, Lesem M D, Swann A C. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992; 149: 108–111
   PubMed Web of Science ®Google Scholar
• Frye M A, Altshuler L L, Bitran J A. Clozapine in rapid cycling bipolar disorder. J Clin Psychopharmacol 1996; 16: 87–90
   PubMedGoogle Scholar
• Garfinkel P E, Stancer H C, Persad E. A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. J Affect Disord 1980; 2: 279–288
   PubMed Web of Science ®Google Scholar
• Geddes J, Freemantle N, Harrison P, Bebbington P. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ 2000; 321: 1371–1376
   PubMed Web of Science ®Google Scholar
• Goldberg J F, Garno J L, Leon A C, Kocsis J H, Portera L. Rapid titration of mood stabilizers predicts remission from mixed or pure mania in bipolar patients. J Clin Psychiatry 1998; 59: 151–158
   PubMed Web of Science ®Google Scholar
• Green Al, Tohen M, Patel J K, Banov M, DuRand C, Berman I, Chang H, Zarate C, Jr., Posener J, Lee H, Dawson R, Richards C, Cole J O, Schatzberg A F. Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry 2000; 157: 982–986
   PubMed Web of Science ®Google Scholar
• Grunze H, Erfurth A, Amann B, Giupponi G, Kammerer C, Walden J. Intravenous valproate loading in acutely manic and depressed bipolar I patients. J Clin Psychopharmacol 1999; 19: 303–309
   PubMed Web of Science ®Google Scholar
• Grunze H, Kasper S, Goodwin G, Bowden C, Baldwin D, Licht R W, Vieta E, Möller H J. WFSBP Task Force on Treatment Guidelines for Bipolar Disorders (2002) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Bipolar Disorders, Part I: Treatment of Bipolar Depression. World J Biol Psychiatry, 3: 115–124
   PubMedGoogle Scholar
• Hesslinger B, Normann C, Langosch J M, Klose P, Berger M, Walden J. Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients. J Clin Psychopharmacol 1999; 19: 310–315
   PubMed Web of Science ®Google Scholar
• Himmelhoch J M, Garfinkel M E. Sources of lithium resistance in mixed mania. Psychopharmacol Bull 1986; 22: 613–620
   PubMed Web of Science ®Google Scholar
• Jacobsen F M. Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome. J Clin Psychiatry 1993; 54: 229–234
   PubMed Web of Science ®Google Scholar
• James A C, Javaloyes A M. The treatment of bipolar disorder in children and adolescents. J Child Psychol Psychiatry 2001; 42: 439–449
   PubMedGoogle Scholar
• Johnstone E C, Crow T J, Frith C D, Owens D G. The Northwick Park ‘functional’ psychosis study: diagnosis and treatment response. Lancet 1988; 2: 119–125
   PubMed Web of Science ®Google Scholar
• Joyce P R. Carbamazepine in rapid cycling bipolar affective disorder. Int Clin Psychopharmacol 1988; 3: 123–129
   PubMed Web of Science ®Google Scholar
• Keck P E, Ice K. Ziprasidone in acute mania. 2000, APA Abstract Nr 224
   Google Scholar
• Keck P E, McElroy S L. Outcome in the pharmacologic treatment of bipolar disorder. J Clin Psychopharmacol 1996; 16: 155–235
   Google Scholar
• Keck P E, McElroy S L, Tugrul K C, Bennett J A. Valproate oral loading in the treatment of acute mania. J Clin Psychiatry 1993; 54: 305–308
   PubMed Web of Science ®Google Scholar
• Keck P E, Strakowski S M, Hawkins J M, Dunayevich E, Tugrul K C, Bennett J A, McElroy S L. A pilot study of rapid lithium administration in the treatment of acute mania. Bipolar Disord 2001; 3: 68–72
   PubMed Web of Science ®Google Scholar
• Kessler R C, Avenevoli S, Ries M K. Mood disorders in children and adolescents: an epidemiologic perspective. Biol Psychiatry 2001; 49: 1002–1014
   PubMed Web of Science ®Google Scholar
• Knoll J, Stegman K, Suppes T. Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania. J Affect Disord 1998; 49: 229–233
   PubMed Web of Science ®Google Scholar
• Kowatch R A, Suppes T, Carmody T J, Bucci J P, Hume J H, Kromelis M, Emslie G J, Weinberg W A, Rush A J. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2000; 39: 713–720
   PubMed Web of Science ®Google Scholar
• Kusumakar V, Yatham L N, Haslam D R, Parikh S V, Matte R, Silverstone P H, Sharma V. Treatment of mania, mixed state, and rapid cycling. Can J Psychiatry 1997; 42((Suppl 2))79S–86S
   Google Scholar
• Lancon C, Llorca P M. Clozapine et traitement des troubles bipolaires a cycles rapides. Encephale 1996; 22: 468–469
   PubMedGoogle Scholar
• Lehman A F, Steinwachs D M. Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophr Bull 1998; 24: 1–10
   PubMed Web of Science ®Google Scholar
• Licht R W. Drug treatment of mania: a critical review. Acta Psychiatr Scand 1998; 97: 387–397
   PubMed Web of Science ®Google Scholar
• Licht R W, Couliaev G, Vestergaard P, Dybbro J, Lund H, Merinder L. Treatment of manic episodes in Scandinavia: the use of neuroleptic drugs in a clinical routine setting. J Affect Disord 1994; 32: 179–185
   PubMed Web of Science ®Google Scholar
• Licht R W, Gouliaev G, Vestergaard P, Frydenberg M. Generalisability of results from randomised drug trials. A trial on antimanic treatment. Br J Psychiatry 1997; 170: 264–267
   PubMed Web of Science ®Google Scholar
• McElroy S L, Keck P E, Stanton S P, Tugrul K C, Bennett J A, Strakowski S M. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry 1996a; 57: 142–146
   PubMed Web of Science ®Google Scholar
• McElroy S L, Pope H G, Keck P E, Hudson Jl, Phillips K A, Strakowski S M. Are impulse-control disorders related to bipolar disorder?. Compr Psychiatry 1996b; 37: 229–240
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Rosen A M, Caracci G, Shukla S. Persistent tardive dyskinesia in bipolar patients. Arch Gen Psychiatry 1986; 43: 342–346
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Sackeim H A, Schnur D B. Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. Am J Psychiatry 1994; 151: 169–176
   PubMed Web of Science ®Google Scholar
• Müller P, Heipertz R. Zur Behandlung manischer Psychosen mit Clozapin. Fortschr Neurol Psychiatr Grenzgeb 1977; 45: 420–424
   PubMedGoogle Scholar
• Poolsup N, Li-Wan P A, De Oliveira I R. Systematic overview of lithium treatment in acute mania. J Clin Pharm Ther 2000; 25: 139–156
   PubMed Web of Science ®Google Scholar
• Pope H G, McElroy S L, Keck P E, Hudson JL. Valproate in the treatment of acute mania. A placebo-controlled study. Arch Gen Psychiatry 1991; 48: 62–68
   PubMed Web of Science ®Google Scholar
• Post R M, Ketter T A, Denicoff K, Pazzaglia P J, Leverich G S, Marangell L B, Callahan A M, George M S, Frye M A. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology 1996; 128: 115–129
   PubMed Web of Science ®Google Scholar
• Pridmore S, Belmaker R. Transcranial magnetic stimulation in the treatment of psychiatric disorders. Psychiatry Clin Neurosci 1999; 53: 541–548
   PubMed Web of Science ®Google Scholar
• Prien R F, Caffey E M, Klett C J. Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiatry of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiatry 1972; 26: 146–153
   PubMed Web of Science ®Google Scholar
• Sachs G, Grossman F, Okamoto A, Ghaemi S N, Bowden C L. Risperidone plus mood stabilizer versus placebo plus mood stabilizer for acute mania of bipolar disorder: a double-blind comparison of efficacy and safety. Am J Psychiatry 2002; 159: 1146–1154
   PubMed Web of Science ®Google Scholar
• Secunda S K, Swann A, Katz M M, Koslow S H, Croughan J, Chang S. Diagnosis and treatment of mixed mania. Am J Psychiatry 1987; 144: 96–98
   PubMed Web of Science ®Google Scholar
• Segal J, Berk M, Brook S. Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol 1998; 21: 176–180
   PubMed Web of Science ®Google Scholar
• Sharma V, Persad E, Mazmanian D, Karunaratne K. Treatment of rapid cycling bipolar disorder with combination therapy of valproate and lithium. Can J Psychiatry 1993; 38: 137–139
   PubMedGoogle Scholar
• Small J G, Klapper M H, Kellams J J, Miller M J, Milstein V, Sharpley P H, Small I F. Electroconvulsive treatment compared with lithium in the management of manic states. Arch Gen Psychiatry 1988; 45: 727–732
   PubMed Web of Science ®Google Scholar
• Suppes T, McElroy S L, Gilbert J, Dessain E C, Cole J O. Clozapine in the treatment of dysphoric mania. Biol Psychiatry 1992; 32: 270–280
   PubMed Web of Science ®Google Scholar
• Suppes T, Phillips K A, Judd C R. Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: a report of three cases. Biol Psychiatry 1994; 36: 338–340
   PubMedGoogle Scholar
• Swann A C, Bowden C L, Morris D, Calabrese J R, Petty F, Small J, Dilsaver S C, Davis J M. Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 1997a; 54: 37–42
   PubMed Web of Science ®Google Scholar
• Swann A C, Bowden C L, Morris D, Calabrese J R, Petty F, Small J, Dilsaver S C, Davis J M. Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 1997b; 54: 37–42
   PubMed Web of Science ®Google Scholar
• Swann A C, Bowden C L, Calabrese J R, Dilsaver S C, Morris D D. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry 2000a; 156: 1264–1266
   Google Scholar
• Swann A C, Bowden C L, Calabrese J R, Dilsaver S C, Morris D D. Mania: differential effects of previous depressive and manic episodes on response to treatment. Acta Psychiatr Scand 2000b; 101: 444–451
   PubMed Web of Science ®Google Scholar
• Tohen M, Zarate C A. Antipsychotic agents and bipolar disorder. J Clin Psychiatry 1998; 59(Suppl 1)38–48
   PubMed Web of Science ®Google Scholar
• Tohen M, Sanger T M, McElroy S L, Tollefson G D, Chengappa K N, Daniel D G, Petty F, Centorrino F, Wang R, Grundy S L, Greaney M G, Jacobs T G, David S R, Toma V. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 1999; 156: 702–709
   PubMed Web of Science ®Google Scholar
• Tohen M, Jacobs T G, Grundy S L, McElroy S L, Banov M C, Janicak P G, Sanger T, Risser R, Zhang F, Toma V, Francis J, Tollefson G D, Breier A. Efficacy of olanzapine in acute bipolar mania: A double-blind, placebo-controlled study. Arch Gen Psychiatry 2000; 57(9)849
   Google Scholar
• Vasudev K, Goswami U, Kohli K. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder. Psycho-pharmacology Berl 2000; 150: 15–23
   PubMed Web of Science ®Google Scholar
• Vieta E, Gasto C, Colom F, Reinares M, Martinez-Aran A, Benabarre A, Akiskal H S. Role of risperidone in bipolar II: an open 6-month study. J Affect Disord 2001; 67: 213–219
   PubMed Web of Science ®Google Scholar
• Wehr T A, Goodwin F K. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 1979; 36: 555–559
   PubMed Web of Science ®Google Scholar
• Whitlock F A, Evans L E. Drugs and depression. Drugs 1978; 15: 53–71
   PubMedGoogle Scholar
• Yaroslavsky Y, Grisaru N, Chudakov B, Belmaker R H. Is TMS therapeutic in mania as well as in depression?. Electroencephalogr Clin Neurophysiol Suppl 1999; 51: 299–303
   PubMedGoogle Scholar
• Yatham L N. Efficacy and tolerability of risperidone as combination therapy in bipolar mania: Results from a randomised, double-blind study (RIS-INT-46). Eur Neuropsychopharmacol 2000; 10((Suppl 3))250
   Google Scholar